<DOC>
	<DOCNO>NCT01091870</DOCNO>
	<brief_summary>A Randomized Clinical Trial security dose test Sildenafil Citrate patient subarachnoid hemorrhage due rupture cerebral aneurism prevention cerebral vasospasm . The cerebral vasospasm decrease blood flow occur intracranial vessel lose capability self-control dilation contraction . Patients subarachnoid hemorrhage without neurological deficit underwent endovascular surgical correction aneurysm participate trial . They randomize daily dos 75 mg Sildenafil , 150 mg Sildenafil Placebo third 14th day post bleeding . Today proven clinical treatment prevention cerebral vasospasm .</brief_summary>
	<brief_title>Sildenafil Prevention Cerebral Vasospasm</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Rupture</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Males females 20 80 year old Subarachnoid hemorrhage confirm CT Fisher III IV criterion ( blood cistern large 1 mm without blood ventricular system ) . Aneurysm detect conventional angiography , angioCT angio MRI . Patient underwent surgery clip endovascular treatment first 72 hour ictus . Consent form sign patient legal responsible . Patient ( legal responsible ) refuse participate . Impossibility collect consent form . Hemodynamical instability . Previous cardiac ischemic disease . History cardiac arrhythmia within last 6 month . History Retinitis Pigmentosa . Previous use drug witch interact sildenafil ( specially nitrate ) . Pregnancy . Known hypersensibility Sildenafil .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Aneurysm</keyword>
	<keyword>Vasospasm</keyword>
	<keyword>sildenafil</keyword>
	<keyword>Viagra</keyword>
</DOC>